SCHEMBL6178067

SCHEMBL6178067

O=S(=O)(c1ccc(CCl)cc1)N1CCCC1c1ccc(F)cc1

nearest known ligand 0.80

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.80
PSEN1 P49768 2/20 0.52
PSEN2 P49810 2/20 0.52
APH1B Q8WW43 2/20 0.52
NCSTN Q92542 2/20 0.52
APH1A Q96BI3 2/20 0.52
PSENEN Q9NZ42 2/20 0.52
HTR7 P34969 2/20 0.45
LMNA P02545 2/20 0.45
CASP3 P42574 1/20 0.44
CASP7 P55210 1/20 0.44
MAPT P10636 2/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
ATM Q13315 1/20 0.43
THRB P10828 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6178073 1.00 TRPA1 (0.80) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178865 0.89 TRPA1 (1.00) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178870 0.89 TRPA1 (1.00) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6181834 0.88 TRPA1 (0.80) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6177461 0.88 TRPA1 (0.80) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6177734 0.88 TRPA1 (0.80) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6177464 0.88 TRPA1 (0.80) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6181831 0.88 TRPA1 (0.80) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6177742 0.88 TRPA1 (0.80) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6177006 0.86 TRPA1 (0.86) TRPA1PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
EP-1165510-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-02 EP disclosed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US disclosed
WO-2000058285-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2000-10-05 WO disclosed